Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Phase II Data May Be Good Sign For 8mg Aflibercept, But Will Payers Bite?
Feb 14 2022
•
By
Alaric DeArment
Regeneron announced Phase II data for aflibercept 8mg in wet AMD • Source: Shutterstock
More from Sensory
More from Therapy Areas